Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genscript Biotech Corp (1548) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8160
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genscript Biotech Corp (Genscript Biotech) is a biotechnology company that provides life sciences research and application services and products. The company offers wide range of services in peptide synthesis, gene synthesis, protein expression and engineering, molecular biology, custom antibody development and engineering, animal model development, and in vitro and in vivo pharmacology. Its product portfolio comprises antibodies, recombinant proteins, stable cell lines, molecular biology reagents, peptides and biochemicals, CRISPR Cas9 reagents and others. The company’s products and services find application in life science research, vaccine development, immunotherapy, and drug discovery and development. It has presence in the US, China and Japan. Genscript Biotech is headquartered in Nanjing, Jiangsu, China.

Genscript Biotech Corp (1548) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11
Licensing Agreements 12
Bliss Biopharma Enters into Licensing Agreement with Genscript Biotech 12
Janssen Biotech Enters into Licensing Agreement with Legend Biotech 13
Equity Offering 14
Genscript Biotech to Raise Funds through Private Placement of Shares 14
Genscript Biotech Completes Underwriters Exercise of Over-Allotment Option of IPO for USD77.7 Million 15
Acquisition 17
Genscript Biotech Acquires Customarray 17
Genscript Biotech Corp – Key Competitors 18
Genscript Biotech Corp – Key Employees 19
Genscript Biotech Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 27, 2018: Genscript Biotech: Announcement of unaudited consolidated interim results for the six months ended June 30, 2018 21
Aug 28, 2017: Genscript Biotech: Announcement Of Unaudited Consolidated Interim Results For The Six Months Ended June 30, 2017 22
Mar 20, 2017: Genscript Biotech: Annual Results Announcement For The Year Ended December 31, 2016 25
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11
Bliss Biopharma Enters into Licensing Agreement with Genscript Biotech 12
Janssen Biotech Enters into Licensing Agreement with Legend Biotech 13
Genscript Biotech to Raise Funds through Private Placement of Shares 14
Genscript Biotech Completes Underwriters Exercise of Over-Allotment Option of IPO for USD77.7 Million 15
Genscript Biotech Acquires Customarray 17
Genscript Biotech Corp, Key Competitors 18
Genscript Biotech Corp, Key Employees 19
Genscript Biotech Corp, Subsidiaries 20

List of Figures
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genscript Biotech Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genscript Biotech Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Martinrea International Inc:企業の戦略・SWOT・財務分析
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Viavi Solutions Inc
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Innovate Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase …
  • Finbar Group Ltd (FRI):企業の財務・戦略的SWOT分析
    Finbar Group Ltd (FRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Connexus Credit Union:企業の戦略的SWOT分析
    Connexus Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Myriad Genetics Inc (MYGN):企業の財務・戦略的SWOT分析
    Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aker BioMarine AS:企業の戦略・SWOT・財務分析
    Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report Summary Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Prime Healthcare Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals. The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound h …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-医療機器分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oki Electric Industry Co., Ltd. (6703):企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Nimir Industrial Chemical Ltd (NICL):企業の財務・戦略的SWOT分析
    Summary Nimir Industrial Chemical Ltd (NICL) is a chemical company that develops, manufactures and distributes oleo chemicals and chlor alkali. The company offers products such as stearic acid, soap noodles, glycerin, caustic soda, sodium hypochlorite, and hydrochloric acid, among others. It also pr …
  • Advanced Sterilization Products Services Inc:製品パイプライン分析
    Summary Advanced Sterilization Products Services Inc (ASP) is a healthcare service provider that offers infection prevention solutions and educational programs for healthcare facilities. The company offers products such as medical device sterilization systems, high-level disinfection products and de …
  • Misawa Homes Co Ltd:企業の戦略・SWOT・財務情報
    Misawa Homes Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Misawa Homes Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Greene King Plc
    Greene King Plc - Strategy, SWOT and Corporate Finance Report Summary Greene King Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Compal Electronics, Inc.:企業の戦略・SWOT・財務情報
    Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pratt & Whitney Canada Corp.:企業の戦略・SWOT・財務情報
    Pratt & Whitney Canada Corp. - Strategy, SWOT and Corporate Finance Report Summary Pratt & Whitney Canada Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dowa Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆